Trial intelligence / Profile preview

Estradiol for the Prevention of Intrusive Memories After Analog Trauma

NCT07419594Recruiting

Sponsor
Charité – Universitätsmedizin Berlin
Start
Aug 2024
Primary completion
Dec 2027
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of estradiol valerate in post-traumatic stress disorder (PTSD) (3 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Change of Intrusive Memories at 4 days. Started Aug 2024; status: recruiting.

02

Drugs

estradiol valerate
03

Conditions

post-traumatic stress disorder (PTSD)

Beyond the preview

Go deeper on NCT07419594.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07419594.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call